Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hyperlipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02023879
What this trial is testing

Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

Who this might be right for
Hypercholesterolemia
Sanofi 233
Large-scale testing (Phase 3)Study completedNCT03872232
What this trial is testing

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

Who this might be right for
HypercholesterolemiaHypertension
Addpharma Inc. 180
Not applicableStudy completedNCT05559606
What this trial is testing

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

Who this might be right for
Primary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 1,839
Not applicableStudy completedNCT06025721
What this trial is testing

Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness

Who this might be right for
Heart DiseasesDiabetes Mellitus, Type 2Pre-diabetes+2 more
Katherine Vickery 9
Not applicableUnknownNCT05473325
What this trial is testing

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

Who this might be right for
DiabetesChronic Kidney DiseasesCancer+25 more
Willows Health 2,000
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Post-approval studies (Phase 4)Study completedNCT00653796
What this trial is testing

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 148
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Testing effectiveness (Phase 2)Study completedNCT01279590
What this trial is testing

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Who this might be right for
MyalgiaHypercholesterolemiaHyperlipidemia
Furiex Pharmaceuticals, Inc 282
Large-scale testing (Phase 3)Study completedNCT05260411
What this trial is testing

Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 246
Post-approval studies (Phase 4)Ended earlyNCT00427960
What this trial is testing

Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

Who this might be right for
Hypercholesterolaemia
AstraZeneca 55
Early research (Phase 1)Study completedNCT01012219
What this trial is testing

Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 36
Large-scale testing (Phase 3)Study completedNCT01228032
What this trial is testing

The Health Outcomes Management and Evaluation (HOME) Study

Who this might be right for
DiabetesHyperlipidemiaHeart Disease+1 more
Emory University 447
Testing effectiveness (Phase 2)Study completedNCT01812707
What this trial is testing

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan

Who this might be right for
Hypercholesterolemia
Sanofi 100
Not applicableEnded earlyNCT01743313
What this trial is testing

Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement

Who this might be right for
HyperglycemiaHypercholesterolemiaPersistent Postoperative Pain+2 more
Coxa, Hospital for Joint Replacement 155
Not applicableStudy completedNCT06301906
What this trial is testing

Red Yeast Rice for Primary Prevention of Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Chang Gung Memorial Hospital 41
Large-scale testing (Phase 3)Study completedNCT00651404
What this trial is testing

Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 137
Large-scale testing (Phase 3)Study completedNCT04849000
What this trial is testing

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipemia
Jiangsu HengRui Medicine Co., Ltd. 709
Not applicableEnrolling By InvitationNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Large-scale testing (Phase 3)Study completedNCT01709513
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 314
Next Page